Ministry of Health and Welfare pre-announced revision of "Details on criteria and methods for the application of Medical Care Benefit"

On July 16, Ministry of Health and Welfare pre-announced revision of "Details on criteria and methods for the application of Medical Care Benefit", and plan to gather opinion till July 27.

First, they decided to acknowledge administration criteria of anticoagulation agent Eliquis (apixaban), Pradaxa (dabigatran etexilate), and Zarelto (rivaroxaban) on high-risk patients with nonvalvular atrial...